Just a quick follow up note on an earlier post. It looks like Medicare Part D is having the effect on drug company profits, and on taxpayers’ wallets, that was predicted and was discussed here. The New York Times has the confirmation here.
Medicare Part D
Part D, Medicare and Economic Distortions
By Stephen Rosenberg on
The New York Times provides an excellent report today on the impact of Medicare Part D and the unintended – maybe(?) – result of moving millions of lower income patients from Medicaid to Medicare. The article points out that drug company profits will increase significantly because the patients are moved from Medicaid, which has certain…